NEW YORK, July 30, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA). Shareholders who purchased shares of WBA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/walgreens-boots-alliance-inc-loss-submission-form/?id=92731&from=3 CL ...

SAN DIEGO, July 29, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) securities between October 12, 2023 and June 26, 2024, inclusive (the “Class Period”), have until September 10, 2024 to seek appointment as lead plaintiff of the Walgreens class action lawsuit. Captioned Bhaila v. Walgreens Boots Alliance, Inc., No. 24-cv-05907 (N.D. Ill.), the Walgreens class action lawsuit charges Walgreens as ...

NEW YORK, July 29, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA).Shareholders who purchased shares of WBA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/walgreens-boots-alliance-inc-loss-submission-form/?id=92373&from=4 CLASS PER ...

SAN DIEGO, July 26, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Walgreens Boots Alliance, Inc. (NASDAQ: WBA) securities between October 12, 2023 and June 26, 2024. Walgreens is a global company that delivers retail and pharmacy, and healthcare services across the United States, Europe, and Latin America. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at ( ...

NEW YORK, July 25, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA).Shareholders who purchased shares of WBA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/walgreens-boots-alliance-inc-loss-submission-form/?id=91986&from=4CLASS PERI ...

NEW ORLEANS, July 24, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 10, 2024 to file lead plaintiff applications in a securities class action lawsuit against Walgreens Boots Alliance, Inc. (NasdaqGS: WBA), if they purchased the Company’s securities between October 12, 2023 to June 26, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of Illinois. Get Help ...

Will the company take the necessary steps to stop the stock's free fall?Walgreens Boots Alliance (WBA -0.62%) is a stock that's in deep trouble. Its future is uncertain, the business isn't performing well, and investors have all but abandoned it. Despite trading at a significantly reduced valuation and at prices not seen in multiple decades, there isn't overwhelming interest from investors to take a chance on this struggling stock.There are, however, many things Walgreens can do and many levers it can pull ...

Lawsuit Overview - The law firm Robbins Geller Rudman & Dowd LLP announced a class action lawsuit against Walgreens Boots Alliance Inc (WBA) for alleged violations of the Securities Exchange Act of 1934 [1] - The class period for the lawsuit is between October 12 2023 and June 26 2024 with the deadline for lead plaintiff motions set for September 10 2024 [1] Allegations Against Walgreens - The lawsuit alleges that Walgreens made false and/or misleading statements during the class period [2] - Defendants allegedly created a false impression of reliable information regarding Walgreens' projected revenue outlook and growth while minimizing risks from seasonality and macroeconomic fluctuations [2] - Walgreens' pharmacy division was not equipped to handle industry challenges and required significant restructuring for sustainability [2] Financial Impact - On June 27 2024 Walgreens announced Q3 2024 results below expectations and lowered FY 2024 projections [3] - Walgreens' CEO cited a difficult operating environment including persistent pressures on US consumers and eroded pharmacy margins [3] - Following the announcement Walgreens' stock price fell more than 22% [3] Lead Plaintiff Process - Investors who purchased or acquired Walgreens securities during the class period can seek appointment as lead plaintiff [4] - The lead plaintiff represents all class members and selects the law firm to litigate the case [4] - Serving as lead plaintiff is not a requirement for sharing in any potential future recovery [4]

NEW YORK, July 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of CVS Health Corporation (NYSE: CVS) and Walgreens Boots Alliance, Inc. (NASDAQ: WBA). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided. CVS Health Corporation (NYSE: CVS) Class Perio ...

SAN DIEGO, July 22, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Walgreens Boots Alliance, Inc. (NASDAQ: WBA) securities between October 12, 2023 and June 26, 2024. Walgreens is a global company that delivers retail and pharmacy, and healthcare services across the United States, Europe, and Latin America. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at ( ...